Related Experiment Video
Updated: Aug 25, 2026

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma
Raina Goyal1, Patrick Watts, Carol M Lane
1Department of Ophthalmology, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, United Kingdom.
Purpose:
To evaluate the effects of steroid injections for periocular capillary hemangioma on adrenal function and body composition.
Design:
Noncomparative, interventional case series.
Participants:
Four patients with periocular hemangioma.
Methods:
Four white female infants with sight-threatening periocular hemangiomata received a combination of steroid injections of triamcinolone and betamethasone. In the first 2 cases, injections were perilesional and in the other 2, intralesional.
Main Outcome Measures:
The infants were monitored by serial measurements of basal serum cortisol concentrations, responses to the Synacthen stimulation test, measurement of growth and of weight gain, and, in one case, more detailed anthropometric measures of body composition.
Results:
Prolonged suppression of circulating serum cortisol concentrations and cortisol responses to the Synacthen stimulation test were noted in 3 cases, and marked failure to thrive was noted in all 4 cases.
Conclusions:
Adrenal suppression after steroid injection for periocular capillary hemangioma is a potentially life-threatening complication. Failure to thrive is also a frequent side effect of treatment. Ophthalmologists should undertake the above treatment in consultation with a pediatric endocrinologist.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...